CoChat

Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor

Kawabata, Takumi, Tanimura, Susumu, Asai, Kohei, Kawasaki, Ryohei, Matsumaru, Yumi, Kohno, Michiaki · 2012 · Journal of Biological Chemistry
Cited by 22

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.319426

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
FIGURE3 CombinationofPD0325901andeithervincristineorpaclitaxelinducesup-regulationofBimanddown-regulationofMcl-1inHT-1080cells. A , HT-1080 cells were synchronized at the G 1 -S boundary by a double thymidine block and then released into the cell cycle. At 1 h after release from the block, the cells were incubated in the absence (control) or presence of 1 𝛍 M PD0325901, 1 nM vincristine ( VCR ), or the combination of these agents. The cells were observedbytime-lapse microscopy to determine the timing of mitotic entry ( left ) or were fixed at the indicated times after release from the block and analyzed for DNA content by flow cytometry ( right ). B , HT-1080 cells were synchronized at the G 1 -S boundary, released into the cell cycle, and incubated in the presence of 1 nM vincristine or 100 nM paclitaxel ( PTX ) alone or in combination with 1 𝛍 MPD0325901asdescribedabove.Adherentcells (3 h after release from the block) were collected by scraping, whereas mitotic cells were collected by gentle shaking at the indicated times after release from the block. For reference, synchronized cells were incubated with or without 1 𝛍 M PD0325901, and total cells were collected at the indicated times after release from the block. Cell lysates (25 𝛍 g of protein) were then subjected to immunoblot analysis with antibodies to the indicated proteins. The brackets indicate Bim EL , and open and closed arrowheads indicate the cleaved and intact forms of poly(ADP-ribose) polymerase ( PARP ), respectively.
FIGURE3 CombinationofPD0325901andeithervincristineorpaclitaxelinducesup-regulationofBimanddown-regulationofMcl-1inHT-1080cells. A , HT-1080 cells were synchronized at the G 1 -S boundary by a double thymidine block and then released into the cell cycle. At 1 h after release from the block, the cells were incubated in the absence (control) or presence of 1 𝛍 M PD0325901, 1 nM vincristine ( VCR ), or the combination of these agents. The cells were observedbytime-lapse microscopy to determine the timing of mitotic entry ( left ) or were fixed at the indicated times after release from the block and analyzed for DNA content by flow cytometry ( right ). B , HT-1080 cells were synchronized at the G 1 -S boundary, released into the cell cycle, and incubated in the presence of 1 nM vincristine or 100 nM paclitaxel ( PTX ) alone or in combination with 1 𝛍 MPD0325901asdescribedabove.Adherentcells (3 h after release from the block) were collected by scraping, whereas mitotic cells were collected by gentle shaking at the indicated times after release from the block. For reference, synchronized cells were incubated with or without 1 𝛍 M PD0325901, and total cells were collected at the indicated times after release from the block. Cell lysates (25 𝛍 g of protein) were then subjected to immunoblot analysis with antibodies to the indicated proteins. The brackets indicate Bim EL , and open and closed arrowheads indicate the cleaved and intact forms of poly(ADP-ribose) polymerase ( PARP ), respectively.CC-BY · From the PDF
FIGURE 4 Loss of Bim expression suppresses enhanced cell death induced by combination of PD0325901 and vincristine in HT-1080 cells. A , HT-1080 cells were transfected for 48 h with Bim ( #1 or #2 ) or control siRNAs and then exposed to 1 𝛍 MPD0325901for12h.Celllysates(25 𝛍 gofprotein) were subjected to immunoblot analysis with antibodies to the indicated proteins. The bracket indicates Bim EL , and the asterisk indicates nonspecific signals. B , HT-1080 cells transfected with control or Bim siRNAs for 48 h were treated with PD0325901 ( PD ) or vincristine ( VCR ) as indicated and observed by time-lapse microscopy for 48 h. Fate profiles of 100 representative cells are shown for each condition ( left ). The numbers of cells that died in mitosis were also determined ( right ). **, p < 0.01.
FIGURE 4 Loss of Bim expression suppresses enhanced cell death induced by combination of PD0325901 and vincristine in HT-1080 cells. A , HT-1080 cells were transfected for 48 h with Bim ( #1 or #2 ) or control siRNAs and then exposed to 1 𝛍 MPD0325901for12h.Celllysates(25 𝛍 gofprotein) were subjected to immunoblot analysis with antibodies to the indicated proteins. The bracket indicates Bim EL , and the asterisk indicates nonspecific signals. B , HT-1080 cells transfected with control or Bim siRNAs for 48 h were treated with PD0325901 ( PD ) or vincristine ( VCR ) as indicated and observed by time-lapse microscopy for 48 h. Fate profiles of 100 representative cells are shown for each condition ( left ). The numbers of cells that died in mitosis were also determined ( right ). **, p < 0.01.CC-BY · From the PDF
FIGURE 5 Stabilization of Mcl-1 slows onset of HT-1080 cell death induced by combination of PD0325901 and vincristine. A , HT-1080 cells were subjected to mock transfection ( Parent ) or transfected for 72 h with control or Mule siRNAs, after which total RNA was isolated and subjected to RT-PCR analysis with primers specific for Mule or GAPDH. B , HT-1080 cells were transfected for 36 h with Mule or control siRNAs, synchronized at the G 1 -S boundary by a double thymidine block, and then released into the cell cycle. After 1 h, the cells were exposed to the combination of 1 𝛍 MPD0325901( PD ) and 1 nM vincristine ( VCR ), and mitotic cells were collected by gentle shaking at the indicated times after release from the block. Cell lysates (25 𝛍 g of protein) were subjected to immunoblot analysis with antibodies to the indicated proteins. C , HT-1080 cells were transfected and exposed to drugs as described for B and were observed by time-lapse microscopy to determine the timing of mitotic entry (0 min) and the timing of death in mitosis ( left ). Data are means ± S.D. ( n = 100 cells). Box-and-whisker plots show the time that cells spent arrested before death in mitosis ( right ). **, p < 0.01.
FIGURE 5 Stabilization of Mcl-1 slows onset of HT-1080 cell death induced by combination of PD0325901 and vincristine. A , HT-1080 cells were subjected to mock transfection ( Parent ) or transfected for 72 h with control or Mule siRNAs, after which total RNA was isolated and subjected to RT-PCR analysis with primers specific for Mule or GAPDH. B , HT-1080 cells were transfected for 36 h with Mule or control siRNAs, synchronized at the G 1 -S boundary by a double thymidine block, and then released into the cell cycle. After 1 h, the cells were exposed to the combination of 1 𝛍 MPD0325901( PD ) and 1 nM vincristine ( VCR ), and mitotic cells were collected by gentle shaking at the indicated times after release from the block. Cell lysates (25 𝛍 g of protein) were subjected to immunoblot analysis with antibodies to the indicated proteins. C , HT-1080 cells were transfected and exposed to drugs as described for B and were observed by time-lapse microscopy to determine the timing of mitotic entry (0 min) and the timing of death in mitosis ( left ). Data are means ± S.D. ( n = 100 cells). Box-and-whisker plots show the time that cells spent arrested before death in mitosis ( right ). **, p < 0.01.CC-BY · From the PDF
Image 6
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., and Yoshida, O. (1995) Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55, 4182-4187
  2. Hoshino, R., Chatani, Y., Yamori, T., Tsuruo, T., Oka, H., Yoshida, O., Shimada, Y., Ari-i, S., Wada, H., Fujimoto, J., and Kohno, M. (1999) Con- stitutive activation of the 41/43-kDa mitogen-activated protein kinase sig- naling pathway in human tumors. Oncogene 18, 813-822 · DOI · Paper page
  3. Hynes, N. E., and Lane, H. A. (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354 · DOI · Paper page
  4. Downward, J. (2003) Targeting RAS signaling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22 · DOI · Paper page
  5. Wellbrock, C., Karasarides, M., and Marais, R. (2004) The RAF proteins take center stage. Nat. Rev. Mol. Cell Biol. 5, 875-885 · DOI · Paper page
  6. Lewis, T. S., Shapiro, P. S., and Ahn, N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49 -139 · DOI · Paper page
  7. Sebolt-Leopold, J. S., and Herrera, R. (2004) Targeting the mitogen-acti- vated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4, 937-947 · DOI · Paper page
  8. Kohno, M., and Pouyssegur, J. (2006) Targeting the ERK signaling path- way in cancer therapy. Ann. Med. 38, 200 -211 · DOI · Paper page
  9. Hoshino, R., Tanimura, S., Watanabe, K., Kataoka, T., and Kohno, M. (2001) Blockade of the extracellular signal-regulated kinase pathway in- duces marked G 1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27 Kip1 . J. Biol. Chem. 276, 2686 -2692 · DOI · Paper page
  10. Tanimura, S., Asato, K., Fujishiro, S. H., and Kohno, M. (2003) Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/9/14 and CD44. Biochem. Biophys. Res. Commun. 304, 801-806 · DOI
  11. Tanimura, S., Uchiyama, A., Watanabe, K., Yasunaga, M., Inada, Y., Kawa- bata, T., Iwashita, K., Noda, S., Ozaki, K., and Kohno, M. (2009) Blockade of constitutively activated ERK signaling enhances cytotoxicity of micro- tubule-destabilizing agents in tumor cells. Biochem. Biophys. Res. Com- mun. 378, 650 -655 · doi:10.1016/j.bbrc.2008.11.109
  12. Yeh, T. C., Marsh, V., Bernat, B. A., Ballard, J., Colwell, H., Evans, R. J., Parry, J., Smith, D., Brandhuber, B. J., Gross, S., Marlow, A., Hurley, B., Lyssikatos, J., Lee, P. A., Winkler, J. D., Koch, K., and Wallace, E. (2007) Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. Clin. Can- cer Res. 13, 1576 -1583 · DOI · Paper page
  13. Rinehart, J., Adjei, A. A., Lorusso, P. M., Waterhouse, D., Hecht, J. R., Natale, R. B., Hamid, O., Varterasian, M., Asbury, P., Kaldjian, E. P., Gu- lyas, S., Mitchell, D. Y., Herrera, R., Sebolt-Leopold, J. S., and Meyer, M. B. (2004) Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small cell lung, breast, colon, and pancreatic cancer. J. Clin. Oncol. 22, 4456 -4462 · DOI · Paper page
  14. Adjei, A. A., Cohen, R. B., Franklin, W., Morris, C., Wilson, D., Molina, J. R., Hanson, L. J., Gore, L., Chow, L., Leong, S., Maloney, L., Gordon, G., Simmons, H., Marlow, A., Litwiler, K., Brown, S., Poch, G., Kane, K., Haney, J., and Eckhardt, S. G. (2008) Phase I pharmacokinetic and phar- macodynamic study of the oral, small-molecule mitogen-activated pro- tein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. J. Clin. Oncol. 26, 2139 -2146 · DOI · Paper page
  15. Youle, R. J., and Strasser, A. (2008) The Bcl-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59 · DOI · Paper page
  16. MacKeigan, J. P., Collins, T. S., and Ting, J. P. (2000) MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem. 275, 38953-38956 · DOI · Paper page
  17. McDaid, H. M., Lopez-Barcons, L., Grossman, A., Lia, M., Keller, S., Pérez- Soler, R., and Horwitz, S. B. (2005) Enhancement of the therapeutic effi- cacy of Taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. Cancer Res. 65, 2854 -2860 · DOI
  18. Watanabe, K., Tanimura, S., Uchiyama, A., Sakamoto, T., Kawabata, T., Ozaki, K., and Kohno, M. (2010) Blockade of the extracellular signal- regulated kinase pathway enhances the therapeutic efficacy of microtu- bule-destabilizing agents in human tumor xenograft models. Clin. Cancer Res. 16, 1170 -1178 · DOI
  19. Musacchio, A., and Salmon, E. D. (2007) The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379 -393 · DOI · Paper page
  20. Tamemoto, H., Kadowaki, T., Tobe, K., Ueki, K., Izumi, T., Chatani, Y., Kohno, M., Kasuga, M., Yazaki, Y., and Akanuma, Y. (1992) Biphasic ac- tivation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267, 20293-20297 · DOI · Paper page
  21. Iwasaki, S., Iguchi, M., Watanabe, K., Hoshino, R., Tsujimoto, M., and Kohno, M. (1999) Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J. Biol. Chem. 274, 26503-26510 · DOI · Paper page
  22. Tanimura, S., Hirano, A. I., Hashizume, J., Yasunaga, M., Kawabata, T., Ozaki, K., and Kohno, M. (2007) Anticancer drugs up-regulate HspBP1 and thereby antagonize the prosurvival function of Hsp70 in tumor cells. J. Biol. Chem. 282, 35430 -35439 · DOI
  23. Rieder, C. L., and Maiato, H. (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637-651 · DOI · Paper page
  24. Blagosklonny, M. V. (2007) Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 6, 70 -74 · DOI · Paper page
  25. Weaver, B. A., and Cleveland, D. W. (2005) Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8, 7-12 · DOI · Paper page
  26. Kaestner, P., and Bastians, H. (2010) Mitotic drug targets. J. Cell. Biochem. 111, 258 -265 · DOI
  27. Janssen, A., and Medema, R. H. (2011) Mitosis as an anticancer target. Oncogene 30, 2799 -2809 · DOI
  28. Hans, F., and Dimitrov, S. (2001) Histone H3 phosphorylation and cell division. Oncogene 20, 3021-3027 · DOI · Paper page
  29. Blagosklonny, M. V. (2001) Unwinding the loop of Bcl-2 phosphorylation. Leukemia 15, 869 -874 · DOI
  30. Zhong, Q., Gao, W., Du, F., and Wang, X. (2005) Mule/ARF-BP1, a BH3- only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121, 1085-1095 · DOI · Paper page
  31. Harley, M. E., Allan, L. A., Sanderson, H. S., and Clarke, P. R. (2010) Phosphorylation of Mcl-1 by CDK1-cyclin B 1 initiates its Cdc20-depen- dent destruction during mitotic arrest. EMBO J. 29, 2407-2420 · DOI · Paper page
  32. Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., and Wang, X. (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17, 1475-1486 · DOI · Paper page
  33. Cuconati, A., Mukherjee, C., Perez, D., and White, E. (2003) DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 17, 2922-2932 · DOI · Paper page
  34. Jackson, J. R., Patrick, D. R., Dar, M. M., and Huang, P. S. (2007) Targeted antimitotic therapies: can we improve on tubulin agents? Nat. Rev. Cancer 7, 107-117 · DOI · Paper page
  35. Fennell, D. A., Chacko, A., and Mutti, L. (2008) Bcl-2 family regulation by the 20 S proteasome inhibitor bortezomib. Oncogene 27, 1189 -1197 · DOI
  36. Kohno, M., Tanimura, S., and Ozaki, K. (2011) Targeting the extracellular signal-regulated kinase pathway in cancer therapy. Biol. Pharm. Bull. 34, 1781-1784 · DOI

Cited by

See all 22

Metadata

Authors
Kawabata, T., Tanimura, S., Asai, K., Kawasaki, R., Matsumaru, Y., & Kohno, M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-03
Volume
287
Issue
13
Pages
10289-10300
ISSN
0021-9258
Cited by
22
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.